✦ For YouGeopoliticsTechFinanceHealthEnergySportsCulture◆ SN Last Week★ Saved

Health·2,849 stories

Health News — Page 72

Ultra-low doses could bring costly cancer treatments to more patients in poorer countries

Ultra-low doses could bring costly cancer treatments to more patients in poorer countries

Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.

STAT News · 2mo ago
Scripps Finds STING Switch Fuels Alzheimer Inflammation

Scripps Finds STING Switch Fuels Alzheimer Inflammation

Scripps researchers identified that a chemical modification of the STING protein drives chronic brain inflammation in Alzheimer’s disease. Blocking this switch in mice reduced inflammation and protect

Science Daily · 2mo ago
Fox Chase study: Melanoma peaks in middle‑aged mice

Fox Chase study: Melanoma peaks in middle‑aged mice

A new study from Fox Chase Cancer Center shows that melanoma metastasis is lowest in young mice, spikes in middle‑aged mice, and falls again in very old mice. The pattern links to a decline in protect

Science Daily · 2mo ago
U.S. military strike kills 3, death toll hits 205

U.S. military strike kills 3, death toll hits 205

The U.S. military conducted a Saturday strike on an alleged drug‑smuggling boat in the eastern Pacific, killing three men and raising the campaign’s death toll to 205 in a month‑long operation.

AP News · 2mo ago
Daraxonrasib Doubles Survival in Pancreatic Cancer

Daraxonrasib Doubles Survival in Pancreatic Cancer

A 500‑patient trial of the KRAS‑targeting pill daraxonrasib showed metastatic pancreatic cancer patients lived an average of 13.2 months—about twice as long as those on chemotherapy—while experiencing

The Guardian Science · 2mo ago
Daraxonrasib doubles survival for pancreatic cancer

Daraxonrasib doubles survival for pancreatic cancer

A pivotal trial of Revolution Medicines’ KRAS‑G12C inhibitor daraxonrasib showed pancreatic cancer patients lived nearly twice as long as those on standard chemotherapy, a result hailed as practice‑ch

STAT News · 2mo ago
PROTEUS Trial Finds Hormone Therapy Beats Single

PROTEUS Trial Finds Hormone Therapy Beats Single

A Phase 3 PROTEUS trial showed that giving high‑risk prostate cancer patients two hormone drugs before and after prostatectomy outperforms the standard single‑drug regimen. The findings, hailed as a “

STAT News · 2mo ago
Ivonescimab Cuts Death Risk 34% in Chinese Lung Study

Ivonescimab Cuts Death Risk 34% in Chinese Lung Study

A Chinese‑run trial of ivonescimab, a dual‑action lung‑cancer drug, cut death risk by 34% in squamous non‑small cell patients, far surpassing standard therapy. The results, unveiled at ASCO and publis

STAT News · 2mo ago
Intermittent fasting triggers surprising changes in the brain

Intermittent fasting triggers surprising changes in the brain

Losing weight may involve rewiring the gut and the brain at the same time

Science Daily · 2mo ago
How Turkey Hacked the Hair Transplant Industry

How Turkey Hacked the Hair Transplant Industry

Turkey’s hair‑transplant sector has become a $3 billion engine of medical tourism, driven by cheap, high‑volume procedures that rely on hacked equipment and algorithmic methods. The boom fuels cultura

Wired · 2mo ago
Fish oil lowers insulin resistance in non‑obese rats

Fish oil lowers insulin resistance in non‑obese rats

A Brazilian‑funded study showed that fish oil supplementation reduces insulin resistance, improves blood sugar control, and lowers cholesterol in non‑obese type 2 diabetes rats. The findings highlight

Science Daily · 2mo ago
BioNTech Pfizer bispecifics; FDA Pazdur restructure

BioNTech Pfizer bispecifics; FDA Pazdur restructure

At the ASCO meeting, BioNTech and Pfizer unveiled new bispecific antibody data, while FDA official Rick Pazdur framed the agency’s current challenges as a chance to restructure. The juxtaposition high

STAT News · 2mo ago
Cancer jab can eradicate entire tumours in patients, trial shows

Cancer jab can eradicate entire tumours in patients, trial shows

A triple‑action cancer jab, amivantamab, showed dramatic tumor shrinkage and complete eradication in a multinational trial of patients with resistant head‑neck cancer. The subcutaneous therapy, develo

The Guardian Science · 2mo ago
Rick Pazdur urges FDA overhaul as China drug rivals

Rick Pazdur urges FDA overhaul as China drug rivals

Former FDA oncology chief Rick Pazdur warned that Trump‑era appointees caused extensive damage to the agency, but he sees the fallout as a rare chance to rebuild the FDA from the ground up. He propose

STAT News · 2mo ago
Revolution Medicines Ships Experimental Pancreatic Drug

Revolution Medicines Ships Experimental Pancreatic Drug

Revolution Medicines has begun delivering its experimental pancreatic‑cancer drug daraxonrasib to patients under an FDA‑authorized early‑access program. The drug, not yet approved, showed in a Phase 3

STAT News · 2mo ago
Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim

Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim

A massive NHS trial of Grail’s Galleri multi‑cancer blood test, involving nearly 143 k asymptomatic adults, failed to cut late‑stage cancer diagnoses, missing its primary endpoint. While the test show

The Guardian Science · 2mo ago
Melatonin Boosts DNA Repair in Night‑Shift Workers

Melatonin Boosts DNA Repair in Night‑Shift Workers

While SKIMNEWS has been tracking Meta’s AI push on Threads and Strategy’s $1.5 billion convertible‑debt retirement, a new BMJ‑published trial shows that a modest melatonin supplement can boost DNA rep

Science Daily · 2mo ago
Trump Doctor Says He’s Excellent, Urges Weight Loss

Trump Doctor Says He’s Excellent, Urges Weight Loss

Amid high‑stakes diplomatic moves, a massive legal battle, and a $10 B+ weekly funding request, Trump’s latest medical memo says he’s in excellent health but needs to shed weight and exercise more. Th

BBC Health · 2mo ago
Blue Micromoon Peaks May 31 — But It Won't Be Blue

Blue Micromoon Peaks May 31 — But It Won't Be Blue

A 'blue micromoon' rises on May 31 — the month's second full moon, also coinciding with the moon's farthest orbital point. Despite the name, the moon won't appear blue, and UK viewers won't see this c

The Guardian Science · 2mo ago
Cathy Tie launches VC‑backed embryo‑editing startup

Cathy Tie launches VC‑backed embryo‑editing startup

Canadian entrepreneur Cathy Tie—dubbed “Biotech Barbie”—is launching a venture‑backed startup to edit embryos for disease prevention, promising transparent, regulator‑approved work after a high‑profil

The Guardian Science · 2mo ago

Get the Health newsletter

Curated health stories, every morning. Free.

No spam. Unsubscribe anytime.